Nonsteroidal Anti-inflammatory Drug
Assets acting on this target.
- Class
- Cyclooxygenase Inhibitors
- Notes
- openFDA EPC fill 2026-08-24 (exact-name label match: naproxen); source: https://api.fda.gov/drug/label.json?search=openfda.generic_name%3A%22naproxen%22+openfda.brand_name%3A%22naproxen%22&limit=12
By indication
Related mechanisms
Nonsteroidal Anti-inflammatory Drug drugs compared
6 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Aspirin/Acetaminophen/Caffeine (Excedrin Migraine)Excedrin Migraine | Haleon US Holdings | Not recorded | Approved | Approved in Migraine |
| Diclofenac potassium (Cambia)Cambia | Aralez Pharmaceuticals Canada Inc., Cosette Pharmaceuticals | small molecule | Approved | Approved in Migraine |
| Ibuprofen (Advil Migraine)Advil Migraine Liqui-Gels | Haleon US Holdings | small molecule | Approved | Approved in Migraine |
| Meloxicam/Rizatriptan (Symbravo)Symbravo | Axsome Therapeutics | small molecule | Approved | Approved in Migraine |
| Sumatriptan/naproxen sodium (Treximet) | Azurity Pharmaceuticals | small molecule | Approved | Approved in Migraine |
| Rizatriptan/naproxen | Eurofarma Laboratorios | small molecule | Phase 3 | Phase 3 in Migraine |